ClinicalTrials.Veeva

Menu

Cancer Survivors Acute Exercise Response 1

University of Houston logo

University of Houston

Status

Unknown

Conditions

Neoplasms Malignant

Treatments

Other: Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT03903848
STUDY00001419

Details and patient eligibility

About

The aims of this study examine the immune system, muscle metabolism, and autonomic nervous system response to an acute bout of exercise. Cancer survivors will participate in an acute bout of exercise. Blood samples will be collected before the exercise bout and at two time points after the exercise bout to assess the proposed variables.

Enrollment

18 estimated patients

Sex

All

Ages

40 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between the ages of 40-70 years

    • At least two years past detectible cancer (two years disease-free survival)
    • Have received chemotherapy and/or radiation as part of their cancer treatment
    • All cancers were of the organs/non-blood producing tissues (not blood/hematologic cancers) and while they were an adult (no history of pediatric cancer)
    • Meeting ACSM-AHA guidelines for exercise (150 minutes per week of cardiorespiratory fitness type exercises and ~two days per week of resistance training), as confirmed by a combination of a physical activity questionnaire and a cardiorespiratory fitness classification of "good" or higher (age and sex matched)
    • A BMI between 20-33 kg·m-2
    • Able to speak and read English

Exclusion criteria

Participants may not:

  • Have any contraindications to moderate to vigorous exercise
  • Have any recent illness or have been instructed not to exercise by a healthcare provider
  • Participants may not have range of motion restrictions that would prevent them from participating in aerobic or resistance training with proper form (they must be ambulatory)
  • Be taking medications (prescription or over the counter) known to influence immune function (including daily NSAID's and beta blockers), cholesterol-lowering medications (statins), drugs that increase bone mass (bisphosphonates), or steroids.
  • Have known cardiovascular, respiratory, metabolic, or renal disease, with the exception of controlled hypertension (as defined by resting BP below 140/90) and/or controlled asthma (self-reported).
  • Be pregnant
  • Be unable to complete all visits (i.e. must not be planning to leave the Houston area long-term before concluding their participation in the study)
  • Fall outside of a BMI range of (20 - 33)
  • Consume alcohol or recreational drugs for 24h prior to visits
  • Participants must not have scheduling conflicts that would prevent them from reporting to the laboratory of integrated physiology 2-3 times over the course of the study

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

18 participants in 1 patient group

Exercise session
Experimental group
Description:
One session of physical exercise
Treatment:
Other: Exercise

Trial contacts and locations

0

Loading...

Central trial contact

Melissa Markofski, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems